Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Lung Cancer

Treatments: Behavioral: semi-structured interviews

Study type: Observational

Funder types: Other

Identifiers

NCT01466946

11-109

Details and patient eligibility

About

The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
• 18 years of age or older
• Fluent in English or Spanish
• Patients must reside in the U.S

Exclusion criteria

• Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)

Trial design

25 participants in 1 patient group

semi-structured interviews

Description:

A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.

Treatment:

Behavioral: semi-structured interviews